diarrhea in Extended release study [Outliers]

posted by dshah  – India/United Kingdom, 2020-09-24 14:05 (1366 d 06:04 ago) – Posting: # 21936
Views: 1,505

Dear Researcher!

It is better to exclude the subject from study.

For XR- your PI shall confirm to exclude participant on clinical ground.


Complete thread:

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,664 registered users;
35 visitors (0 registered, 35 guests [including 6 identified bots]).
Forum time: 20:09 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz